MR
Maury Raycroft Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
69.2%
Neutral
30.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $43 |
27%
upside
| 1 | +8.8% |
0
%
| 3 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $81 |
2%
upside
| 1 | +48% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $63 |
179%
upside
| 1 | +15% |
0
%
| 30 Dec ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $0.5000 |
28%
upside
| 1 | -41% |
–
| 30 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $134 |
18%
upside
| 1 | +15% |
0
%
| 2 Dec ‘25 3 months ago |
|
|
|
Buy
Upgraded
| $21 |
46%
upside
| 1 | +3% |
0
%
| 7 Nov ‘25 4 months ago |
|
|
|
Hold
Downgraded
| $1.60 |
32%
upside
| 1 | – |
–
| 31 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $549 |
70%
upside
| 2 | +6.1% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Hold
Downgraded
| $7 |
0%
upside
| 1 | – |
–
| 17 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $15 |
42%
downside
| 1 | +170% |
0
%
| 22 Sep ‘25 5 months ago |
|
|
|
Hold
Initiated
| $3.50 |
76%
upside
| 1 | – |
–
| 24 Jun ‘25 8 months ago |
|
|
|
Buy
Maintained
| $53 |
455%
upside
| 1 | +41% |
0
%
| 11 Mar ‘25 1 year ago |
|